Apogee Therapeutics to Participate in Upcoming March Conferences Feb 24, 2026 07:30AM
Apogee Therapeutics to Participate in Upcoming Conferences Nov 3, 2025 07:30AM
Apogee Therapeutics closes $345 million public offering Oct 10, 2025 04:01PM
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million Oct 10, 2025 04:01PM
Apogee Therapeutics prices $300 million stock offering at $41 per share Oct 8, 2025 09:52PM


Oct 8, 2025 09:52PM Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering
Oct 8, 2025 04:01PM Apogee Therapeutics announces underwritten public stock offering
Oct 8, 2025 04:01PM Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
Jun 11, 2025 09:32AM TD Cowen: 'Own Apogee Therapeutics Inc (APGE)'
Mar 10, 2025 02:16PM TD Cowen Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)
Feb 25, 2025 07:30AM Apogee Therapeutics to Participate in Upcoming March Investor Conferences
Mar 12, 2024 04:01PM Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million
Mar 8, 2024 05:21AM Apogee Therapeutics (APGE) Prices Upsized 6.77M Share Offering at $62/sh
Mar 7, 2024 06:49PM Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
Mar 5, 2024 04:23PM Apogee Therapeutics (APGE) Announces $350M Share Offering
Mar 5, 2024 04:23PM Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
Jul 18, 2023 04:01PM Apogee Therapeutics, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Jun 22, 2023 04:23PM Apogee Therapeutics (APGE) Announces Proposed IPO